Citations

Mayo Clinic

Showing 10 of 108551 citations.

Global trends and outcomes of nerve transfers for treatment of adult brachial plexus injuries
Crowe, Christopher S. , Spinner, Robert J. , Shin, Alexander Y. , Shin, Alexander Y

Journal of Hand Surgery (European Volume) | February 19, 2024 | Volume: 49 | Issue: 9 | Pages: 1147-1156

10.1177/17531934241232062 | PMID 38372245 Get It

The presentation, management and outcomes of brachial plexus injuries are likely to be subject to regional differences across the globe. A comprehensive literature search was performed to identify relevant articles related to spinal accessory to suprascapular, intercostal to musculocutaneous, and ulnar and/or median nerve fascicle to biceps and/or brachialis motor branch nerve transfers for treatment of brachial plexus injuries. A total of 6007 individual brachial plexus injuries were described with a mean follow-up of 38 months. The specific indication for accessory to suprascapular and intercostal to musculocutaneous transfers were considerably different among regions (e.g. upper plexus vs. pan-plexal), while uniform for fascicular transfer for elbow flexion (e.g. upper plexus +/− C7). Similarly, functional recovery was highly variable for accessory to suprascapular and intercostal to musculocutaneous transfers, while British Medical Research Council grade ≥3 strength after fascicular transfer for elbow flexion was frequently obtained. Overall, differences in outcomes seem to be inherent to the specific transfer being utilized. Level of evidence: III
Ki-67 Proliferation Index Is Associated With Tumor Grade and Survival in Pleural Epithelioid Mesotheliomas
Galeano, Belinda, Smith, Caleb J. , Yi, Eunhee S. , Roden, Anja C. , Jenkins, Sarah M. , Capelle, Jenna, Kittle-Francis, Mary, Aubry, Marie Christine, Mansfield, Aaron S.

American Journal of Surgical Pathology | February 19, 2024 | Volume: 48 | Issue: 5 | Pages: 615-622

10.1097/pas.0000000000002196 | PMID 38369761 Get It

Pleural epithelioid mesothelioma (PEM) is divided into low and high grades based on nuclear atypia, mitoses, and necrosis in the tumor. Assessing mitoses and nuclear atypia tend to be labor-intensive with limited reproducibility. Ki-67 proliferation index was shown to be a prognostic factor in PEM, but its performance has not been directly correlated with tumor grade or mitotic score. This study evaluated the potential of Ki-67 index as a surrogate of tumor grade. We also compared the predictability of mitoses and Ki-67 index for overall survival (OS). Ninety-six PEM samples from 85 patients were identified from the surgical pathology file during 2000-2021 at our institution, and all glass slides were reviewed by 2 pulmonary pathologists to confirm the diagnosis and assign the tumor grade. Digital image analysis (DIA) was done for Ki-67 index. The agreement on tumor grading between 2 reviewers was moderate (kappa value = 0.47). The correlation between mitotic count (average count by 2 reviewers) and Ki-67 index was 0.65. The areas under the curve for predicting tumor grade by mitotic score and Ki-67 index were 0.84 and 0.74 (reviewer 1) and 0.85 and 0.81 (reviewer 2), respectively. High Ki-67 index and mitoses were significantly associated with poor OS (P=0.03 and 0.0005, using 30% and 10/2 mm2 as cutoffs, respectively). In conclusion, Ki-67 index by DIA was associated with tumor grade as well as mitotic count, and its predictability for OS was comparable to that of mitotic score, thus being a potential surrogate for tumor grade.
Clinical Implications of Subclinical Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction: The PARAGON-HF Study
Minamisawa, Masatoshi, Claggett, Brian , Čikeš, Maja , Liu, Li , Prasad, Narayana , Biering‐Sørensen, Tor , O’Meara, Eileen , Redfield, Margaret M. , Solomon, Scott D. , Shah, Amil M. , Shah, Amil , Inciardi, Riccardo M. , Lam, Carolyn S.P. , Shah, Sanjiv J , Zile, Michael R. , McMurray, John J.V. , Solomon, Scott David

European Journal of Heart Failure | February 19, 2024 | Volume: 26 | Issue: 4 | Pages: 871-881

10.1002/ejhf.3167 | PMID 38369856 Get It

Abstract Aims Left ventricular (LV) subclinical impairment has been described in heart failure with preserved ejection fraction (HFpEF). We assessed the relationship between LV myocardial deformation by strain imaging and recurrent hospitalization for heart failure (HF) or cardiovascular death in a large international HFpEF population. Methods and results We assessed two-dimensional speckle-tracking based global longitudinal strain (GLS) in 790 patients (mean age 74 ± 8 years, 54% female) with adequate image quality enrolled in the PARAGON-HF echocardiography study. We examined the relationship of GLS with total HF hospitalizations and cardiovascular death (the primary composite outcome) after accounting for clinical confounders. Approximately 47% of the population had evidence of LV subclinical dysfunction, defined as absolute GLS <16%. Impaired GLS was significantly associated with higher values of circulating baseline N-terminal pro-B-type-natriuretic peptide. After a median follow-up of 3.0 years, there were 407 total HF hospitalizations and cardiovascular deaths. After multivariable adjustment, worse GLS was associated with a greater risk for the primary composite outcome (adjusted hazard ratio per 1% decrease: 1.06; 95% confidence interval 1.02–1.11; p = 0.008). GLS did not modify the treatment effect of sacubitril/valsartan compared with valsartan for the composite outcome (p for interaction >0.1). Conclusions In a large HFpEF population, impaired LV function was observed even among patients with preserved ejection fraction, and was associated with an increased risk of total HF hospitalizations or cardiovascular death, accounting for clinical confounders. These findings highlight the key role of subtle LV systolic impairment in the pathophysiology of HFpEF.
A Survey of Sleep Quality From a Post-COVID Clinic
Punj, Mantavya , Schwartz, Michael , Morris, Anjali, Cheung, Joseph , Munipalli, Bala , Cheung, Joseph

Journal of Primary Care & Community Health | February 19, 2024 | Volume: 15 | Issue: No issue available | Pages: No page available

10.1177/21501319241233205 | PMID 38369723 Get It

Objectives: To assess the prevalence of sleep disturbance among patients evaluated at a clinic for patients afflicted with Post-acute sequelae of COVID-19 (PASC). Methods: Sleep disturbance was assessed with the Patient-Reported Outcomes Measurement Information System-Sleep Disturbance (PROMIS-SD) framework among adult patients of the PASC clinic. Results: Among 312 patients, the mean age was 46.2 years, and 70.2% were women. About 41.0% of patients had no sleep disturbance; sleep disturbance was mild to moderate in 51.3% and severe in 7.7%. PROMIS-SD score was negatively correlated with the time from the initial positive COVID-19 test to the initial consultation in the PASC clinic (Pearson r = −.094; r 2 = .0088). Conclusions: The PROMIS-Sleep Disturbance framework can serve as a tool to assess the burden of sleep disturbances in PASC patients.
Unraveling the directional relationship of sleep and migraine-like pain
Vizin, Robson Cristiano Lillo , Kopruszinski, Caroline Machado , Redman, Paula M, Ito, Hisakatsu , Rau, Jill C. , Navratilova, Edita , Porreca, Frank , Lillo Vizin, Robson C , Navratilova, Edita , Porreca, Frank , Kopruszinski, Caroline , Dodick, David W.

Brain Communications | February 18, 2024 | Volume: 6 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcae051 | PMID 38444905 Get It

Abstract Migraine and sleep disorders are common co-morbidities. Patients frequently link their sleep to migraine attacks suggesting a potential causal relationship between these conditions. However, whether migraine pain promotes or disrupts sleep or whether sleep disruption can increase the risk of migraine remains unknown. We assessed the potential impact of periorbital allodynia, a measure consistent with migraine-like pain, from multiple preclinical models on sleep quantity and quality. Additionally, we evaluated the possible consequences of sleep deprivation in promoting susceptibility to migraine-like pain. Following the implantation of electroencephalogram/electromyography electrodes to record sleep, mice were treated with either single or repeated systemic injections of nitroglycerin at the onset of their active phase (i.e. nocturnal awake period). Neither single nor repeated nitroglycerin affected the total sleep time, non-rapid eye movement sleep, rapid eye movement sleep, sleep depth or other measures of sleep architecture. To account for the possible disruptive effects of the surgical implantation of electroencephalogram/electromyography electrodes, we used immobility recordings as a non-invasive method for assessing sleep-wake behaviour. Neither single nor repeated nitroglycerin administration during either the mouse sleep (i.e. daylight) or active (i.e. night) periods influenced immobility-defined sleep time. Administration of an inflammatory mediator mixture onto the dura mater at either sleep or active phases also did not affect immobility-defined sleep time. Additionally, inhalational umbellulone-induced migraine-like pain in restraint-stressed primed mice did not alter immobility-defined sleep time. The possible influence of sleep disruption on susceptibility to migraine-like pain was evaluated by depriving female mice of sleep over 6 h with novel objects, a method that does not increase circulating stress hormones. Migraine-like pain was not observed following acute sleep deprivation. However, in sleep-deprived mice, subthreshold doses of systemic nitroglycerin or dural calcitonin gene-related peptide induced periorbital cutaneous allodynia consistent with migraine-like pain. Our data reveal that while migraine-like pain does not significantly disrupt sleep, sleep disruption increases vulnerability to migraine-like pain suggesting that a therapeutic strategy focused on improving sleep may diminish migraine attacks.
A script‐enabled interactive checklist document for efficient management of electronic devices in a busy multimodality radiotherapy clinic
Pepin, M. , Brost, Eric E., Klein, Kristi A., Garces, Yolanda I. , Brinkmann, Debra H. , Pepin, Mark D , Brost, Eric

Journal of Applied Clinical Medical Physics | February 18, 2024 | Volume: 25 | Issue: 3 | Pages: No page available

10.1002/acm2.14302 | PMID 38368613 Get It

PurposeDevelop an efficient, interactive, and instructive checklist document for the management of implanted electronic medical devices in a multimodality radiotherapy clinic.MethodsThe built‐in scripting and interactivity of a popular commercial word processor was used to develop an interactive document that changes the information presented to the user based on drop‐down selections. The interactivity and scripting were compatible with the radiation oncology information system (ROIS) which allows the document to be accessible by all team members and serve as a permanent record in a patient's electronic chart.ResultsThe final interactive document, which was clinically deployed after beta testing with a group consisting of nurses and medical physicists, presents information and action plans to the user based on multiple departmental medical device decision trees that are specific to the combination of device, treatment modality, rhythm‐pacing dependence for cardiac devices, and distance from the device to the treatment volume.ConclusionA script‐enabled interactive document was developed for a busy multimodality clinic, condensing multiple comprehensive departmental guidelines spanning multiple device types and treatment modalities into a single interactive checklist accessible within the ROIS. Given the wide accessibility of the commercial word processor, this approach could be adopted by other clinics to streamline their own respective workflows.
Atypical presentations of dicer1 syndrome in adults with juvenile granulosa cell tumor
Hamai, Callie, Salmon, Samantha , Mohammad, Arwa , Goodman, Jean R. , Hunter, Mark , Salmon, Samantha

North American Proceedings in Gynecology & Obstetrics | February 18, 2024 | Volume: 3 | Issue: 2 | Pages: No page available

10.54053/001c.93947 Get It

Appendiceal ganglioneuroma incidentally found during resection of recurrent rectal cancer: case report and review of the literature
Perez, Mauricio E. , Horton, Rachel, Rumer, Kristen K. , Perez Pachon, Mauricio E

Journal of Surgical Case Reports | February 17, 2024 | Volume: 2024 | Issue: 2 | Pages: No page available

10.1093/jscr/rjae019 | PMID 38370592 Get It

Abstract Ganglioneuromas (GN) are benign neuroblastic tumors that arise from neural crest cells. Since they present with nonspecific symptoms, diagnosis is often incidental. We are reporting a case of an adult appendiceal GN incidentally found during rectal cancer surgery. A 42-year-old male was diagnosed with recurrent rectal cancer after experiencing urinary difficulties and buttock pain. A multiple-stage pelvic exenteration was carried out after neoadjuvant chemotherapy and chemoradiation. Prophylactic appendectomy was done during the course of surgery, and pathology reported an appendix with GN at the distal tip. GN are often found incidentally and rarely cause appendicitis. Depending on their location and size, they might become symptomatic. While there is some controversy on whether surgery is the treatment of choice for all GN, diagnosis is rarely apparent preoperatively, and all appendiceal masses should be resected.
Minimum clinical utility standards for wearable seizure detectors: A simulation study
Goldenholz, Daniel M. , Karoly, Philippa J. , Viana, Pedro F. , Nurse, Ewan S. , Bruno, Elisa , Richardson, Mark P. , Brinkmann, Benjamin H. , Westover, M. Brandon , Nurse, Ewan , Schulze-Bonhage, Andreas , Bruno, Elisa , Nasseri, Mona , Richardson, Mark P , Brinkmann, Benjamin H , Karoly, Phillipa J , Goldenholz, Daniel M , Viana, Pedro F , Westover, M Brandon , Loddenkemper, Tobias , Schulze‐Bonhage, Andreas , Vieluf, Solveig

Epilepsia | February 17, 2024 | Volume: 65 | Issue: 4 | Pages: 1017-1028

10.1111/epi.17917 | PMID 38366862 Get It

AbstractObjectiveEpilepsy management employs self‐reported seizure diaries, despite evidence of seizure underreporting. Wearable and implantable seizure detection devices are now becoming more widely available. There are no clear guidelines about what levels of accuracy are sufficient. This study aimed to simulate clinical use cases and identify the necessary level of accuracy for each.MethodsUsing a realistic seizure simulator (CHOCOLATES), a ground truth was produced, which was then sampled to generate signals from simulated seizure detectors of various capabilities. Five use cases were evaluated: (1) randomized clinical trials (RCTs), (2) medication adjustment in clinic, (3) injury prevention, (4) sudden unexpected death in epilepsy (SUDEP) prevention, and (5) treatment of seizure clusters. We considered sensitivity (0%–100%), false alarm rate (FAR; 0–2/day), and device type (external wearable vs. implant) in each scenario.ResultsThe RCT case was efficient for a wide range of wearable parameters, though implantable devices were preferred. Lower accuracy wearables resulted in subtle changes in the distribution of patients enrolled in RCTs, and therefore higher sensitivity and lower FAR values were preferred. In the clinic case, a wide range of sensitivity, FAR, and device type yielded similar results. For injury prevention, SUDEP prevention, and seizure cluster treatment, each scenario required high sensitivity and yet was minimally influenced by FAR.SignificanceThe choice of use case is paramount in determining acceptable accuracy levels for a wearable seizure detection device. We offer simulation results for determining and verifying utility for specific use case and specific wearable parameters.
Clinical Impacts of Implementing the 2021 Race-Free Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate
Meeusen, Jeffrey W. , Wang, Qian

The Journal of Applied Laboratory Medicine | February 17, 2024 | Volume: 9 | Issue: 3 | Pages: 586-598

10.1093/jalm/jfad137 | PMID 38366867 Get It

Abstract Background Estimated glomerular filtration rate (eGFR) has become incorporated into multiple clinical management situations. Historically, equations included a Black race coefficient, which lacked biological plausibility and created potential to exacerbate health disparities. A new equation created in 2021 changed the weighting of age, sex, and creatinine by modeling against a diverse cohort and removing the Black race coefficient. Content A variety of clinical outcomes including kidney disease risk stratification, medication dosing, patient eligibility for clinical trials, and kidney donation are impacted by implementation of the new equation. Nearly 2 years after its initial publication, many studies have reported on observed analytical performance of the 2021 eGFR determined as diagnostic concordance and percentage of estimates within 30% of measured GFR. Additionally, the potential clinical impacts following adoption of the new eGFR among different patient populations has also been reported. Here we review these studies with a focus on assessing the data associated with the transition from 2009 to 2021 Chronic Kidney Disease Epidemiology Collaboration equations. Summary The reported interindividual variation in eGFR performance is significantly larger than any potential benefit derived from race coefficients. Both the 2021 eGFR and the 2009 eGFR analytical performance fall short of the validation cohort performance in most cohorts. However, the 2021 analytical is similar or better than the 2009 eGFR in most cohorts. Implementing the 2021 eGFR will remove a systematic overestimation of kidney function among Black patients.